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RAPPORT DE SYNTHESE 
Introduction La dystrophie musculaire de Duchenne (DMD) est une myopathie progressive liéè au 
chromosome X qui atteint environ un garçon sur 3500. Des troubles du sommeil (TDS) sont 
fréquemment rapportés par ces patients Les études effectuées à ce jour se sont essentiellement 
concentrées sur les troubles respiratoires liés au sommeil. Les TDS débutent toutefois fréquemment 
avant l'installation d'un trouble ventilatoire nocturne et de nombreux autres facteurs peuvent en être la 
cause. 
Objectif L'objectif de cette étude est d'évaluer la fréquence des TDS chez les garçons avec une DMD 
et d'en identifier les facteurs de risque. 
Méthode Il s'agit d'une étude transversale effectuée par questionnaire postal adressé aux parents de 
tout garçon âgé de 4-18 ans avec une DMD, suivi dans deux centres tertiaires de réhabilitation 
pédiatrique (Lausanne et Dublin). Les TDS $ont évalués à l'aide de la 'Sleep Disturbance Scale for 
Children' (SDSC), validée sur 1157 enfants sains. Elle permet d'obtenir un score total et des scores 
pour six facteurs représentant les TDS les plus fréquents (troubles de l'endormissement et du 
maintien du sommeil (TEMS), éveil nocturne-cauchemars, transition veille-sommeil, somnolence 
diurne excessive, troubles respiratoires associés au sommeil (TRS), hyperhidrose du sommeil). Un T-
score supérieur à 70 (>2DS) est considéré comme pathologique. Les associations potentielles entre 
des scores pathologiques et des facteurs individuels (âge, mobilité diurne et nocturne, douleur), 
thérapeµtiques (orthèses nocturnes, ventilation non-invasive, médication) et environnementaux 
(facteurs socio-familiaux) sont évaluées à l'aide d'analyses univariées (x2) et de régressions 
logistiques ascendantes. 
Résultats Seize garçons sur 63, soit 25.4%, présentent un score total pathologique en comparaison 
au 3% attendus dans la population générale. Les TEMS (29.7%), les TRS (15.6%) et l'hyperhidrose 
du sommeil (14.3%) sont les TDS les plus prévalent. 
Le besoin d'être mobilisé la nuit par un tiers (OR=9.4; 95%CI: 2.2-40. 7; p=0.003) et être l'enfant d'une 
famille monoparentale (OR=7.2; 95%CI: 1.5-35.1; p=O. 015) sont des facteurs de risque indépendants 
pour un score total pathologique. Le besoin d'être mobilisé la nuit par un tiers (OR=18.0; 95%CI: 2.9-
110.6; p=0.002), le traitement par corticostéroïdes (OR=?. 7; 95%CI: 1.4-44.0; p=0.021) et être l'enfant 
d'une famille monoparentale (OR=7.0; 95%CI: 1.3-38.4; p=0.025) sont des facteurs de risque 
indépendants pour un TEMS. , 
Discussion Cette étude montre une prévalence élevée des TDS chez les garçons avec une DMD. 
(25% contre 3% attendus dans la population générale). Le besoin d'être mobilisé la nuit par un tiers 
est identifié comme un facteur de risque important pour un score total pathologique et un TEMS. Il 
reflète vraisemblablement un degré d'atteinte motrice tel qu'il limite les mouvements spontanés et les 
adaptations posturales du sommeil, ayant pour conséquence une diminution importante de la qualité 
du sommeil. Les enfants vivant dans un foyer monoparental présentent plus fréquemment un score 
total pathologique et des TEMS, possiblement en lien avec un stress psychologique plus important 
dans ces familles. Le tràitement par corticostéroïdes est identifié comme facteur de risque pour un 
TEMS. Une adaptation du schéma ou du dosage permet généralement de limiter cet effet secondaire .. 
Si nécessaire, un traitement par Mélatonine peut être instauré. 
Aucune association n'a pu être mise en évidence entre les facteurs analysés et les TRS, possiblement 
en raison du petit nombre de garçons ayant rapporté de tels symptômes et du fait que certains 
symptômes d'hypoventilation nocturne ne sont pas évalués par la SDSC. Par ailieurs, la valeur 
prédictive de l'anamnèse, comme celle des fonctions pulmonaires diurnes, est connue pour- être 
limitée, raison pour laquelle une oxy-capnométrie est effectuée de routine en dessous .d'une capacité 
vitale forcée de 50%. Elle permet, si nécessaire, l'instauration précoce d'une ventilation non-invasive, 
limitant ainsi vraisemblablement l'impact de l'hypoventilation nocturne sur la qualité du sommeil dans 
notre population. · 
Plusieurs limitations sont à évoquer. Le petit nombre de patients ne permet pas d'exclure d'autres 
associations potentielles. La nature transversale de l'étude augmente le risque de causalité inverse. 
Cette étude n'inclut pas de mesure quantitative du sommeil. Les questionnaires adressés aux parents 
ont toutefois pu être démontrés comme fiables hormis pour les TRS. Un biais de non-réponse ne peut 
pas être totalement exclu, bien que le taux de réponse soit élevé (86,5%) et qu'il n'y ait pas de 
différence significative entre les populations de répondeurs et non-répondeurs. · · · 
Conclusion La prévalence des TDS est élevée chez les garçons avec une DMD et leurs causes sont 
multiples. Les facteurs de risques sont physiques (immobilité nocturne), pharmacologiques 
(corticothérapie) et environnementaux (famille monoparentale). Compte tenu de son impact sur la 
qualité de vie, l'évaluation du sommeil doit être systématique en consultation et ne pas se limiter aux 
seuls troubles ventilatoires nocturnes. 
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Method: Cross-sectional study by postal questionnair~. Sleep disturbances were 
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sleep disorders were computed. Potential associations between pathological scores and 
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Results: Sixteen of 63 boys (25.40/o) had a pathological total sleep score compared 
with 30/o in the general population. The most prevalent sleep disorders were disorders of 
initiating and maintaining sleep (OlMS) 29.70/o, sleep-related breathing disorders 15.60/o 
and sleep hyperhydrosis 14.30/o. 
On multivariate analysis, pathological total sleep scores were associated with the need to 
be moved by a carer (OR= 9.4; 950/oCI: 2.2-40.7; p = 0.003) and beingthe child of a 
single-parent family (OR= 7.2; 950/oCl: 1.5-35.1; p = 0.015) and DIMS with the need to 
be moved by a carer (OR = 18.0; 950/oCl: 2.9-110.6; p = 0.002), steroid treatment 
(OR= 7.7; 950/oCI: l .4-44.0; p = 0:02 7) and being the child of a single-parent family 
(OR= 7.0; 950/oCl: 1.3-38.4; p = 0.025). 
Conclusion: Sleep disturbances are frequent in boys with OMO and are strongly 
associated with immobility. Sleep should be systematically assessed in OMO to implement 
appropriate interventions. 
INTRODUCTION 
Duchenne Muscular Dystrophy (DMD) is a progressive 
myopathy affecting one in 3,300-6000 live male births (1,2). 
Mutations in the X-linked dystrophin gene result in a loss of 
fonctional dystrophin, an essential element ·for the struc-
tural integrity of muscle cells (3-5), which makes them 
proue to plasma membrane leakage and finally muscle fibre 
degeneration. The disease often manifests with mildly 
delayed motor miles~ones or gait disturbances. The progres-
sive muscle wealmess leads to loss of ambulation at 10-
12 years and finally to cardiac and respiratory insufficiency 
in the late teens. Few persans with DMD survive beyond 
their thirties (2), even with clinical interventions such as 
non-invasive ventilation or steroid therapy. Despite wide-
spread efforts, no curative treatment is currently available 
Abbreviations 
DIMS, Disorders of Initiating and M.aintaining Sleep; DMD, 
Duchenne Muscular Dystrophy; DOA, Dîsorders of Arousal; 
DOES, Dîso1:ders of Excessive Somnolence; NIV, Non-Invasive 
Ventilation; SDSC, Sleep Disturbance Scale for Children; SHY, 
Sleep Hyperhydrosis; SRBD, Sleep-relàted Breathing Disorders; 
SWTD, Sleep-wake Transition Disorders 
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and steroids are still the only treatment proven to slow the 
natural course of the disease ( 6, 7). 
Our clinical experience suggests that DMD is associated 
with disturbed sleep of various origins, of which the most 
studied are sleep-related breathing disorders. These have 
been widely described in the literature (8-10), due to their 
increasing frequency with age and their therapeutic conse-
quences (non-invasive or invasive ventilation) (11,12). 
However, several other sparsely studied factors that are fre-
quently encountered in this population seem to alter these 
children's sl~ep. Musculo-skeletal pain, which is frequent in 
subjects with DMD (13), decreased bed mobility, 
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medication (e.g. oral steroids) or the use of positioning 
devices are ail potential contributors fo sleep difficulties. 
Moreover, primary or secondary behavioural and psycho-
logical problems, as well as familial and social difficulties, 
may adversely affect sleep. 
Until now, sleep disorders in DMD have been mainly stud-
ied in relation to sleep-related breathing disorders, which 
affect non-ambulant patients from their teenage years. 
The aim of our study was to determine the prevalence of 
sleep disorders in boys and teenagers with DMD and to 
identify associated factors by analysing parents' responses 
to a validated sleep disturbance scale. 
METHOD 
Design 
Cross-sectional study conducted by postal questionnaire 
(14). 
Participants 
The target population consisted of all children aged 4-
18 years with a diagnosis of DMD and who were regularly 
followed in two tertiary paediatric neurorehabilitation out-
patient clinics (Paediatric Neurology and Neurorehabilita-
tion Unit, Lausanne University Hospital, Lausanne, 
Switzerland; Central Remedial Clinic, Dublin, Ireland). 
Diagnosis was ascertained by a positive mutation analysis in 
the dystrophin gene (840/o) or by substantially reduced levels 
of dystrophin on biopsy, associated with typical clinical fea-
tures (160/o). Seventy-four children wei:e eligible, 54 in Dub-
lin and 20 in Lausanrte. A èover letter describing the study 
and the validated sleep disturbance scale was sent to the 
parents. Non-responders received a phone reminder from 
the local investigator. Sixty-four questionnaires were 
returned (overall response rate 86.5%), 19 in Lausanne 
(950/o) and 42 in Dublin (77.80/o). Sixty-three questionnaires 
were fully completed. Signed consent for data use was 
obtained for every patient, and the study was approved by 
the Ethics Committee of the University cif Lausanne and the 
Central Remedial Clinic's institutional review board. 
Data· collection 
The Sleep Disturbance Scale for Children (SDSC) was 
selected because of its thorough validation, its good level of 
internal consistency and test-retest reliability, the availabil-
ity of normal data and the overlap of the normative age 
group (6 years 6 months-15 years 4 months) with that 
assessed in the present study. Furthermore, age and sex 
showed no significant effect on total sleep scores in the nor-
mal population. 
The SDSC was originally validated on a randomly selected 
sample of 1157 healthy children from the general popula-
tion. It assesses the sleep behaviour and occurrence of sleep 
disturbances during the previous 6 months (15). The scale 
contains 26 items rated on a Likert-type scale, for example, 
'How many hours sleep does your child get on most nights?' 
(1 indicates 9-11 h, 2 indicate 8-9 h, 3 indicate 7-8 h, 4 
indicate 5-7 h and 5 indicate <5 h) and 'The child startles or 
Bloetzer et al. 
jerks parts of the body while falling asleep' (1 indicates 
never; 2 indicate occasionally [once or twice or I~ss/month]; 
3 indicate sometimes [once to twice/week]; 4 indicate often 
[three to five times/week]; 5 indicate always [daily]). A total 
sleep score is obtained by summing the item scores. The ori-
ginal factor analysis yielded six sleep disturbance factors rep-
resenting the most common areas of sleep disorders in 
childhood and adolescence: (i) Disorders of sleep-related 
breathing (SRBD); (ii) Disorders of initiating and maintain-
ing sleep (DIMS); (iii) Disorders of arousal (DOA); (iv) Dis-
or.ders of sleep-wake transition (SWTD); (v) excessive 
somnolence (DOES); and (vi) sleep hyperhydrosis (SHY). 
For the present study, the original scale was completed 
with items regarding the socio-familial situation (parents' 
marital status and current parental employment), the current 
medication, the use of night postural equipment (positioning 
devices), the use of non-invasive ventilation and/or tube-
feeding, the need to be turned by a. carer during the night and 
the presence ofbed-sharing with parent(s). While answering 
the questionnaire, the parents were asked to consider the 
previous 6 months. Information about motor impairment 
was obtained from the participants' medical files. 
Statistical analysis 
General characteristics of the study population were analy-
sed by frequencies. A total sleep score and scores for the dif-
ferent sleep disturbance factors were computed and 
converted into a binary variable based on n01mative data 
(T-score of more than 70, i.e. >2SD, was regarded as patho-
logical (15)). Total sleep disturbance and individual sleep 
disturbance factors were represented by frequencies. Poten-
tial associations between a pathological sleep sc9re (total 
and individual sleep disturbance factors), age, socio-familial 
situation (parents' marital status, parental unemployment, 
bed-sharing), motor impairment (ambulatory status, moved 
by carer), medical interventions (steroids, use of postural 
equipment, e.g. night-time ankle foot orthotics at least 3 
nights/week, NIV, tube-feeding) and pain were assessed by 
bivariate analyses (/), and cmde odds ratios (OR) with 
their 95% confidence intervals (CI) were computed. For-
ward stepwise logistic regression was thel). conducted to 
identify independent risk factors for pathological total sleep 
score and for each sleep disorder factor. Dummy variables 
were created for categorical parameters. Variables that 
showed no contribution to any of the sleep factors 
(p > 0.20) were excluded from these models. 
Overall mode! evaluation was performed with omnibus 
tests of mode! coefficients. Bach mode! was assessed for 
goodness-of-fit with the Hosmer and Lemeshow x2 statistic 
(p < 0.10 indicating a lack of fit). Analyses were performed 
with SPSS (version 12.0; SPSS Inc., Chicago, IL, USA), and 
p < 0.05 was considered significant. 
RESULTS 
General characteristics 
The study population consisted of 64 boys with a mean age 
of 10.5 years (SD 4.3; range: 4 years 6 months-18 years 
©2012 The Author(s)/Acta Pœdiatrica ©2012 Foundation Acta Pœdiatric.a 
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8 months). For subsequent analysis, they were subdivided 
into three age categories: 4-8 years, 28 children (43.80/o); 9-
13 years, 16 children (250/o); and 14-18 years, 20 children 
(31.30/o). Physical impairment was assessed by ambulatory 
status and by the need to be turned during the night. Thirty-
four children were non-ambulant (53.10/o). Fifteen (23.40/o) 
boys had to be turned during the night, of whom 5 (7.80/o) 
were turned tlu·ee to five nights per week and ten (15.60/o) 
every night. Thirty-five patients were reported to be treated 
with steroids (54.70/o). One patient was treated with melato-
nin. Seven patients (10.90/o) were part-time ventilated (NIV) 
and one patient needed tube-feeding. Night-time postural 
equipment (exclusively ankle foot orthotics) was used by 31 
children (49.20/o): every night by 17 children (270/o), three to 
five nights per week by eight children (12.70/o) and two 
nights or less per week by six children (9.50/o). 
Eleven children lived in a single-parent family- (17.20/o). 
Unemployment was reported in five families (7.80/o). Bed-
sharing was reported at least once a week in 13 families 
(20.30/o): it took place every night in four families (6.30/o), 
three to five nights per week in one family (1.60/o) and one 
to two nights perweek in eight families (12.50/o). 
Sleep disturbance scale for children results 
The total sleep score could be computed for 63 of 64 chil-
dren, of whom 16 (25.40/o) had a pathological score: five 
children in the age category 4-8 years (17.9% of this age 
category), 7 in the age category 9-13 years (43.8%), and 4 in 
the age category 14-18 years (21.1%). 
Disorders in initiating and maintaining sleep (DIMS) 
were observed in 19 children (29.70/o), sleep-related breath-
ing disorders (SRBD) in 10 (15.6%), disorders of arousal 
(DOA) in · 5 (7.8%), sleep-wake transition disorders 
(SWTD) in 6 (9.40/o), excessive somnolence (DOES) in 7 
(10.90/o) and sleep hyperhydrosis (SHY) in 9 (14.30/o). 
Thirty-seven children had none of these sleep disorders 
(58.70/o), 12 experienced one sleep disorder (19%), five pre-
sented two sleep disorders (7.90/o), three and four sleep dis-
orders where each experienced by four children (6.30/o 
each), and one child had all six sleep disorders (1.60/o). For 
one child, the total sleep score could not be computed as 
one question (SHY) remained unanswered. 
The overall model evaluations suggested that'for SRBD, 
DOA, SWTD, DOES and SHY none of the variables were 
significantly associated to the outcome (data not shown). 
On multivariate analysis, a pathological total sleep score 
was significantly associated with the need to be moved by a 
carer (OR= 9.4; 950/oCI: 2.2-40.7; p = 0.003) and being the 
child of a single-parent family (OR= 7 .2; 950/oCI: 1.5-35.1; 
p = 0.015) (Table 1). The multivariate analysis of variables 
associated with a pathological DIMS score (Table 2) 
showed significant associations with the need to be moved 
by a carer (OR= 18.0; 950/oCI: 2.9-110.6; p = 0.002), being 
treated with steroids (OR= 7.7; 950/oCI: 1.4-44; p = 0.021) 
and being the child of a single-parent family (OR= 7.0; 
950/oCI: 1.3-38.4; p = 0.025). 
Bath of these models achieved satisfactory goodness-of-
fit with the Hosmer-Lemeshow x2 statistic (total sleep 
©2012 The Author(s)/Acto Pa=diatrica ©2012 Foundation Acta Prediatriai 
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score: degrees of freedom = 2, x2 = 0.33, p = 0.85; disor-
ders of initiation and maintenance of sleep: degrees of free-
dom = 4, x2 = 2.1, p = 0.72). 
DISCUSSION 
Our study indicates a high prevalence of sleep disturbance 
in patients with DMD. By setting a threshold T-score of 70 
(above 2 standard deviations, i.e. above centile 97) for the 
sleep disturbance scale for children, a pathological total 
sleep score would affect approximately 30/o of children in 
the normal population (15). This threshold was selected to 
5 
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ideritify children who have a clinically significant sleep dis-
order, exceeding common sleep disturbance in childhood. 
In our study population, 250/o of the children had a patho-
logical total sleep score and 420/o experienced at least one 
clinically significant sleep disorder. Furthennore, the preva-
lence was clearly elevated (above 100/o, i.e. more than triple 
the normal population) for the following four sleep factors: 
difficulty in initiating and maintaining sleep (29.70/o), sleep-
related breathing disorders (15.60/o), sleep hyperhydrosis 
(14.30/o) and excessive somnolence (10.90/o). 
The only factors that were associated with a total sleep 
disturbance in the present study were the need to be turned 
and being the child of a single-parent family. This need to be 
moved by a carer most likely indicates a degree of motor 
impairment that does not pennit the usual spontaneous 
movements and postural adaptations that occur during 
sleep and seems to be a major burden on the quality of sleep. 
Furthermore, it was also strongly associated with disorders 
of initiating and maintaining sleep. 
While it has been well descrfbed that healthy young 
adults change position 20-40 times pér night, and children 
even more (16), the exact role of spontaneous movements 
during sleep remains largely unknown. It has been sug-
gested that the sleep position is related to sleep quality and 
some sleep disorders (including breathing disorders). Sorne 
authors hypothesized that spontaneous movement during 
sleep aim to relieve pain secondary to prolonged immobili-
zation (the 'discomfort' theory) (17). 
We failed to demonstrate an association of sleep-related 
breathing disorders with any of the analysed factors. Possi-
ble explanations are the small number of patients in whom 
these disorders were reported, the fact that an adequate 
respiratory follow-up enables early identification and inter-
vention on such clisturbances, and also that certain of the 
common symptoms of night-time hypoventilation such as 
headaches on wakening are not assessed in the SDSC, while 
other symptoms are included in other disorder groups (dis-
orders of excessive somnolence, sleep hyperhidrosis). 
Symptoms of SRBD are often subtle and unspecific in an 
early stage and can therefore easily be missed by carers. 
Both symptoms and lung functions have limited predictive 
value in boys with DMD (8), therefore the diagnosis of 
SRBD in this population relies either on nocturnal poly-
somnography or more frequently on nocturnal pulse oxy-
metry and capnography. These are routinely performed 
once to twice per year after loss of ambulation and/or 
decrease of forced vital capacity below 500/o of the predicted 
value (12), and allow for the prompt institution of NIV 
when required. 
Disorders of initiating and maintaining sleep were signifi-
cantly more frequent in children treated by steroids. Ste-
roids are known to influence sleep behaviour in children 
(18). Even if in our experience, such disturbances have 
never led to an interruption of the treatment, parents should 
be questioned about the subject. Adaptation of the dosage 
or therapeutic plan, or a pharmacological treatment could 
be proposed and improve the symptoms and therefore pos-
sibly the compliance. Medication with a central nervous 
Bloetzer et al. 
system depressant effect should of course be avoided due to 
potential further respiratory compromise, but melatonin, in 
particular the slow-release form, may be considered in case 
of disorders of initiation and maintaining of sleep (19). Chil-
dren living in single-parent families weie also significantly 
more likely to present disorders of initiating and maintain-
ing sleep. Psychosocial stressors have been reported to 
affect the quality of sleep in normal children (20), and these 
are possibly higher in single-parentfamilies. 
The use of night positioning devices showed no signifi-
cant association with any sleep disorder. The main reason 
for thi~ is that they are probably abandoned when they 
affect the child's sleep. 
The main limitation of our study was the limited sample 
size. As for other studies on rare diseases, selection of an 
adequate number of subjects was a major challenge and 
potential associations could have been missed. The data col-
lection was a cross-sectional survey; however, some of the 
subject's characteristics ( diagnosis, treatment, motor 
impairment) were obtained through the medical files and 
had therefore been recorded before the questionnaire was 
sent to the families (at most 6 months prior). Even if our 
study did not include quantitative sleep measurements, 
parental reports have been demonstrated to be reliable in 
detecting sleep disturbance in children compared to objec-
tive measurements (21,22), with the exception of SRBD, 
which would have required a systematic polysomnography 
be performed in al! of our study population, including the 
ambulant children. A certain degree of non-response bias 
cannot be excluded even with a high overall response rate 
(86.50/o). Howevcr, there was no significant difference 
between responders and non-responders when looking for 
known parameters such as age, treatment, motor function 
and environmental factors. The two centres were reference 
clinics for neuromuscular disorders covering the vast major-
ity of patients in their respective regions (French speaking 
Switzerland and Republic of Ireland), and therefore, our 
sample was representative of the DMD population. Finally, 
ascertainment of intellectual impai1111ent was not performed 
due to the difficulties to do this by a posted questionnaire. 
Moreover, the medical file of most patients did not contain 
any objective evaluation. Inte!lectual impairment is, how-
ever, well known to be associated with sleep disturbance 
(23,24) and frequent among boys with DMD, with estimates 
ranging from 200/o to as much as 500/o in some studies 
(25,26). 
CONCLUSION 
Our study suggests that boys affected by DMD are highly 
prone to sleep disturbances and that these are far from 
being due only to sleep-related breathing disorders. We 
demonstrated \hat physical (need to be turned by a carer), 
medical (treatment with steroids) and environmental fac-
tors (single-parent household) may affect these patients 
sleep. Due to their important impact on quality of life, we 
believe that sleep disturbance should not only be assessed 
to detect nocturnal hypoventilation, but also to evaluate 
©2012 The Author(s)/Acta Pœdiatrico ©2012 Foundation Acta Prediatrica 
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other risk factors that could be treated by environmental, 
behavioural or pharmacological interventions. 
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